title: Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.
authors.forename: Jose-Manuel
authors.initials: JM
authors.lastname: Calvo-Villas
authors.forename: Jose Antonio
authors.initials: JA
authors.lastname: Fernández
authors.forename: Ignacio
authors.initials: I
authors.lastname: de la Fuente
authors.forename: Ana Cristina
authors.initials: AC
authors.lastname: Godoy
authors.forename: M Carmen
authors.initials: MC
authors.lastname: Mateos
authors.forename: Concepcion
authors.initials: C
authors.lastname: Poderós
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008081:Liposomes; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D055756:Meningeal Carcinomatosis / Q000188:drug therapy*; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D000964:Antimetabolites, Antineoplastic; D003692:Delayed-Action Preparations; D008081:Liposomes; D003561:Cytarabine